Recent Security Class Actions
Celsion Corporation Common Stock (NASDAQ: CLSN)
Company Name:Celsion Corporation Common Stock
Stock Symbol:NASDAQ: CLSN
Class Period Start:04/15/2020
Class Period End (inclusive):07/13/2020
Filing Deadline:12/28/2020
According to the Complaint, Celsion Corporation is an integrated development clinical stage oncology drug company that focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Celsion’s lead product candidate is ThermoDox, a heat-activated liposomal encapsulation of doxorubicin that is in Phase III clinical development for treating primary liver cancer.
